No abstract

No abstract

Minimally invasive implantation of subdural electrodes can dramatically benefit the patients with various neurological diseases. In modern clinical practice, the implantation procedure of the electrode arrays remains traumatic for patients and increases postoperative infection risk. Here we report a design and insertion technique of thermally activated shape-memory polymer-based electrode array that can recover up to ten times length deformation. The compressed four-centimeter wide array can be easily packed into a three-millimeter diameter tube and subsequently deployed thought five-millimeter opening in a restricted space between a brain phantom and a simulated skull. The mechanical properties of the developed array are comparable to the materials traditionally employed for the purpose, and the electrical and signal recording properties are preserved after shape deformation and recovery. Additionally, the array is biocompatible and exhibits conformability to a curvy brain surface. The results demonstrate that insertion of the electrode array through a small hole into a restricted space similar to subdural cavity is possible, which may inspire future solution of minimal invasive implantation for patients suffering from epilepsy, amyotrophic lateral sclerosis or tetraplegia.

It is widely stated that ascorbic acid (AA) interferes with the electrochemical detection of neurotransmitters, especially dopamine, because of their overlapping oxidation potentials on typical electrode materials. As the concentration of AA is several orders of magnitude higher than the concentration of neurotransmitters, detection of neurotransmitters is difficult in the presence of AA and requires either highly stable AA concentration or highly selective neurotransmitter sensors. In contrast to the common opinion, we show that AA does not always interfere electrochemical detection of neurotransmitters. The decay of AA is rapid in cell culture medium, having a half-time of 2.1 hours, according to which the concentration decreases by 93% in 8 hours and by 99.75% in 18 hours. Thus, AA is eventually no longer detected by electrodes and the concentration of neurotransmitters can be effectively monitored. To validate this claim, we used unmodified single-wall carbon nanotube electrode to measure dopamine at physiologically relevant concentration range (25–1000 nM) from human midbrain organoid medium with highly linear response. Finally, AA is known to affect dopamine oxidation current through regeneration of dopamine, which complicates precise detection of small amounts of dopamine. By designing experiments as described here, this complication can be completely eliminated.

No abstract